Guillermo, Misty Rose 2.

HRN: 19-74-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2022
CEFUROXIME 750MG (VIAL)
12/02/2022
12/03/2022
IV
750 Mg
Q8
Post CS X 3

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Non-compliant To Guidelines